Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
View all
Truvian
San Diego, United States · Series C
Instil Bio
Dallas, United States · IPO
Mission Bio
San Francisco, United States · Series C
Clear Labs
Menlo Park, United States · Series C
Kinnate Biopharma
San Diego, United States · IPO
TrialSpark
New York, United States · Series C
Omega Therapeutics
Cambridge, United States · Post IPO Equity
Zageno
Cambridge, United States · Series C
Vividion Therapeutics
San Diego, United States · Series C
insitro
South San Francisco, United States · Series C
Korro Bio
Cambridge, United States · Series B
Sonoma Biotherapeutics
South San Francisco, United States · Corporate Round